SE220104C1 - - Google Patents

Info

Publication number
SE220104C1
SE220104C1 SE816760A SE816760A SE220104C1 SE 220104 C1 SE220104 C1 SE 220104C1 SE 816760 A SE816760 A SE 816760A SE 816760 A SE816760 A SE 816760A SE 220104 C1 SE220104 C1 SE 220104C1
Authority
SE
Sweden
Application number
SE816760A
Other languages
Slovenian (sl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of SE220104C1 publication Critical patent/SE220104C1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE816760A 1959-08-26 1960-08-26 SE220104C1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM0042545 1959-08-26

Publications (1)

Publication Number Publication Date
SE220104C1 true SE220104C1 (en:Method) 1968-04-23

Family

ID=7304374

Family Applications (1)

Application Number Title Priority Date Filing Date
SE816760A SE220104C1 (en:Method) 1959-08-26 1960-08-26

Country Status (4)

Country Link
CH (1) CH390243A (en:Method)
FR (1) FR297M (en:Method)
GB (1) GB951460A (en:Method)
SE (1) SE220104C1 (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956349A (en) * 1975-02-18 1976-05-11 Syntex (U.S.A.) Inc. Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof

Also Published As

Publication number Publication date
FR297M (fr) 1961-03-13
CH390243A (de) 1965-04-15
GB951460A (en) 1964-03-04

Similar Documents

Publication Publication Date Title
FI41540B (en:Method)
JPS3617204Y1 (en:Method)
JPS377913B1 (en:Method)
JPS369157B1 (en:Method)
SE220104C1 (en:Method)
DE1130183C2 (en:Method)
DE1401743A1 (en:Method)
BE586968A (en:Method)
BE586725A (en:Method)
NL105146C (en:Method)
LU38910A1 (en:Method)
LU38857A1 (en:Method)
NL243513A (en:Method)
NL244731A (en:Method)
NL254115A (en:Method)
NL256875A (en:Method)
NL295236A (en:Method)
BE586432A (en:Method)
CH1168760A4 (en:Method)
BE595169A (en:Method)
BE587162A (en:Method)
BE587160A (en:Method)
BE587087A (en:Method)
BE586995A (en:Method)
BE586364A (en:Method)